{"id":"798894c3-bc3f-5c2d-9666-a1d4eca0e90f","stable_key":"5d8e27d8-6a74-5560-827f-3f90908bbc34:ala-triglyceride-primary-null","predicate":"did_not_reduce","statement":"R-lipoic acid did not reduce the primary fasting-triglyceride outcome in this 24-week trial.","claim_class":"observational","status":"source_derived_draft","evidence_grade":"ungraded","direction":"neutral","is_public":true,"mechanism_event_id":"f5baf7af-7573-5836-a9f7-a895a6d27e68","mechanism_event_label":"The trial’s main blood-fat target did not improve.","subject":{"id":"8eeb8f85-a924-5122-9399-a757b83c668c","slug":"r-lipoic-acid","display_name":"Free R-alpha-lipoic acid","entity_type_key":"small_molecule"},"object":{"id":"ee3cc0cf-97bc-53b7-b10e-c89ac1c1f2cd","slug":"fasting-triglyceride-concentration","display_name":"Fasting triglyceride concentration","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"f5baf7af-7573-5836-a9f7-a895a6d27e68","stable_key":"5d8e27d8-6a74-5560-827f-3f90908bbc34:ala-triglyceride-primary-null-event","event_type":"observed_intervention","label":"The trial’s main blood-fat target did not improve.","description":"R-lipoic acid did not reduce the primary fasting-triglyceride outcome in this 24-week trial.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"8eeb8f85-a924-5122-9399-a757b83c668c","slug":"r-lipoic-acid","display_name":"Free R-alpha-lipoic acid","entity_type_key":"small_molecule"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"ee3cc0cf-97bc-53b7-b10e-c89ac1c1f2cd","slug":"fasting-triglyceride-concentration","display_name":"Fasting triglyceride concentration","entity_type_key":"cellular_process"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""}]},"contexts":[{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/ala-research/32692358.abstract.txt\", \"locator\": \"Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"4054eff822014466ea739125fd4000ba2a5852e5f9818487f0b32b7be2b8d076\", \"start_char\": 0, \"end_char\": 2088, \"text_sha256\": \"4054eff822014466ea739125fd4000ba2a5852e5f9818487f0b32b7be2b8d076\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Randomized placebo-controlled R-lipoic-acid trial","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"R-lipoic acid 600 mg/day for 24 weeks","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"Primary triglyceride outcome was null; BMI was secondary and subgroup findings are exploratory.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Alpha-lipoic acid research collection; topical membership is not evidence of a direct dietary effect.","comparator":null,"unit":null,"notes":"","entity":{"slug":"lipoic-acid","display_name":"Lipoic acid","entity_type_key":"small_molecule"}},{"dimension":"organism","value_text":"Human","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"The trial’s main blood-fat target did not improve.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[ala-p32692358] A Randomized Controlled Trial of Long-Term (R)-α-Lipoic Acid Supplementation Promotes Weight Loss in Overweight or Obese Adults without Altering Baseline Elevated Plasma Triglyceride Concentrations. (2020). https://pubmed.ncbi.nlm.nih.gov/32692358/ DOI: 10.1093/jn/nxaa203","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"81 overweight adults with elevated triglycerides","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"e671e221-0b82-543a-a9b5-45baec20343a","evidence_kind":"source_excerpt","locator":"Lines 1209-1220","start_line":1209,"end_line":1220,"excerpt":"### ala-triglyceride-primary-null\nR-lipoic acid did not reduce the primary fasting-triglyceride outcome in this 24-week trial.\nCondition category: normal\nnutrient_topic: Alpha-lipoic acid research collection; topical membership is not evidence of a direct dietary effect.\nplain_language: The trial’s main blood-fat target did not improve.\norganism: Human\ntissue_or_cell_type: 81 overweight adults with elevated triglycerides\nexperimental_model: Randomized placebo-controlled R-lipoic-acid trial\nlimitations: Primary triglyceride outcome was null; BMI was secondary and subgroup findings are exploratory.\nexposure: R-lipoic acid 600 mg/day for 24 weeks\nevidence_span: {\"source_cache\": \"artifacts/ala-research/32692358.abstract.txt\", \"locator\": \"Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"4054eff822014466ea739125fd4000ba2a5852e5f9818487f0b32b7be2b8d076\", \"start_char\": 0, \"end_char\": 2088, \"text_sha256\": \"4054eff822014466ea739125fd4000ba2a5852e5f9818487f0b32b7be2b8d076\"}\n[ala-p32692358] A Randomized Controlled Trial of Long-Term (R)-α-Lipoic Acid Supplementation Promotes Weight Loss in Overweight or Obese Adults without Altering Baseline Elevated Plasma Triglyceride Concentrations. (2020). https://pubmed.ncbi.nlm.nih.gov/32692358/ DOI: 10.1093/jn/nxaa203","model_system":"Randomized placebo-controlled R-lipoic-acid trial","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [ala-p32692358] A Randomized Controlled Trial of Long-Term (R)-α-Lipoic Acid Supplementation Promotes Weight Loss in Overweight or Obese Adults without Altering Baseline Elevated Plasma Triglyceride Concentrations. (2020). https://pubmed.ncbi.nlm.nih.gov/32692358/ DOI: 10.1093/jn/nxaa203","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"d8afa8c2-ced9-5b28-90ca-2ac120ec7202","stable_key":"import-5d8e27d8-6a74-5560-827f-3f90908bbc34","title":"Alpha-lipoic acid: cofactor assembly, redox signaling and nutrient interactions (2026-09-17)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"611da198ab85a272eb26b64ee330ef6d1a762853a8481f3191c4acfca9f3cf3d","revision_id":"618b4ce6-3157-5222-8325-408064be5ea5","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}